GL1X · GenesisL1 explorer

MolNFT v1 · #171495 · protein

Variant surface glycoprotein vsgsur, I3C ("magic triangle") derivative used for phasing of the structure and subsequently as a model for molecular replacement of native, mutants, and drug soaks.

6Z79 · Variant surface glycoprotein sur: “Variant surface glycoprotein vsgsur, I3C ("magic triangle") derivative used for phasing of the structure and…”. X-ray diffraction, 4 ligands (I3C, NAG, MAN), 1 pocket (best druggability 0.41).…

PDB
6Z79
Type
protein
Length
336 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Variant surface glycoprotein sur
UniProt
A0A291L8F4
Ligands
I3C, NAG, MAN, BMA
Pockets
1 · best druggability 0.41

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVariant surface glycoprotein surprotein33649% helix, 15% strandA0A291L8F4

Ligands and binding sites

  • I3C · 5-amino-2,4,6-triiodobenzene-1,3-dicarboxylic acid · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 2 copies · chains A
  • BMA · beta-D-mannopyranose · sugar

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.410.8215empty

Modifications

Observed in the structure: 3 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 6Z79 · Variant Surface Glycoprotein VSGsur, I3C ("Magic Triangle") derivative used for phasing… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.